Since GDF-15 has potential cell growth promoting activity and its circulating concentrations in type 2 diabetes are elevated, it is logical to regard GDF-15 as a promising candidate for risk assessment for thyroid nodule in type 2 diabetic patients. This evidence concerns the gene GDF15 and thyroid nodule.